Vytrus Biotech SA
MAD:VYT

Watchlist Manager
Vytrus Biotech SA Logo
Vytrus Biotech SA
MAD:VYT
Watchlist
Price: 9.2 EUR Market Closed
Market Cap: 70.3m EUR

Net Margin
Vytrus Biotech SA

28.2%
Current
19%
Average
3.3%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
28.2%
=
Net Income
2m
/
Revenue
6.9m

Net Margin Across Competitors

No Stocks Found

Vytrus Biotech SA
Glance View

Market Cap
69.9m EUR
Industry
Consumer products

Vytrus Biotech SA is a biotechnology company, which engages in the development of cosmetic active ingredients from plant stem cell technology. The company is headquartered in Terrassa, Barcelona and currently employs 28 full-time employees. The company went IPO on 2022-03-24. The firm develops high added value natural active ingredients on an industrial scale and provides ingredients and recombinant proteins for its use in the cosmetics and pharmaceutical sectors. The Company’s technology is based on using plant cell cultures to produce bioactive molecules. The firm obtains plant cells, known as Plant Stem Cell technology, which is applicable for cosmetics.

VYT Intrinsic Value
8.59 EUR
Overvaluation 7%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
28.2%
=
Net Income
2m
/
Revenue
6.9m
What is the Net Margin of Vytrus Biotech SA?

Based on Vytrus Biotech SA's most recent financial statements, the company has Net Margin of 28.2%.

Back to Top